Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

MDWD
MediWound Ltd
stock NASDAQ

At Close
9/28/2023 3:59:59 PM EDT
10.90USD+18.478%(+1.70)95,175
8.72Bid   13.21Ask   4.49Spread IEX
Pre-market
9/21/2023 8:00:30 AM EDT
9.16USD-0.435%(-0.04)0
After-hours
1969-12-31
0.00USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
139.081M
Headquarters
42 Hayarkon Street, Yavne, Israel
Industry
Biotechnology
Next Earnings
2023-11-14 (47d)
Last Split
2022-12-201for7reverse
Related
BSTCJNJSNNTAROTEVAXLV
MDWD Stats
Avg. Vol. 10 Day
32,133
Avg. Vol. 30 Day
35,124
Employees
83
Market Cap
139,081,471
Shares Out.
12,759,768
P/E Ratio
-7.97
EPS (ttm)
-2.010
On/Off Exchange
43%/57%
6 Month Beta
0.21
1 Year Beta
0.66
2 Year Beta
0.60
3 Year Beta
0.65
52 Week Low
7.10
52 Week High
14.58
SMA50
8.64
SMA200
10.21
1 Week
+16.52%
1 Month
+23.86%
3 Month
+6.65%
6 Month
-14.04%
1 Year
+12.03%
2 Year
-55.76%
5 Year
-74.68%
Profile
mediwound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds. mediwound's first innovative biopharmaceutical product, nexobrid®, received marketing authorization from the european medicines agency as well as the israeli and argentinian ministries of health, for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full-thickness thermal burns and was launched in europe israel and argentina. nexobrid represents a new paradigm in burn care management, and clinical trials have demonstrated, with statistical significance, its ability to non-surgically and rapidly remove the eschar earlier and without harming viable tissue. mediwound's second innovative product, escharex®, is a topical biological drug being developed for debridement of chronic and

MDWD Stock Summary

MediWound Ltd (NASDAQ:MDWD) stock price today is $10.90, and today's volume is 95,175. MDWD is up 18.478% today. The 30 day average volume is 35,124. MDWD market cap is 139.081M with 12,759,768 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC